Literature DB >> 17606652

Hyperammonemia due to valproic acid in the psychiatric setting.

Russell B Carr1, Kerrie Shrewsbury.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17606652     DOI: 10.1176/ajp.2007.164.7.1020

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


× No keyword cloud information.
  26 in total

1.  Encephalopathy induced by combination therapy with valproic Acid and topiramate: challenging the utility of serum ammonia measurement.

Authors:  Osric Sin; Josh Batterink
Journal:  Can J Hosp Pharm       Date:  2015 Jan-Feb

2.  Placebo-controlled trial of valproic Acid versus risperidone in children 3-7 years of age with bipolar I disorder.

Authors:  Robert A Kowatch; Russell E Scheffer; Erin Monroe; Sergio Delgado; Mekibib Altaye; Denise Lagory
Journal:  J Child Adolesc Psychopharmacol       Date:  2015-05       Impact factor: 2.576

3.  Reversible Encephalopathy due to Valproic Acid Induced Hyperammonemia in a Patient with Bipolar I Disorder: A Cautionary Report.

Authors:  Neel Patel; Katherine B Landry; Rachel E Fargason; Badari Birur
Journal:  Psychopharmacol Bull       Date:  2017-01-26

Review 4.  Valproate-induced hyperammonaemia superimposed upon severe neuropsychiatric lupus: a case report and review of the literature.

Authors:  Estee Chan; Fiona McQueen
Journal:  Clin Rheumatol       Date:  2012-12-28       Impact factor: 2.980

5.  Valproate Induced Delirium due to Hyperammonemia in a Case of Acute Mania: A Diagnostic Dilemma.

Authors:  Siddharth Dixit; Mayank Namdeo; Sudip Azad
Journal:  J Clin Diagn Res       Date:  2015-04-01

Review 6.  Lesson of the month 1: Sodium valproate-induced encephalopathy.

Authors:  Lara Camilleri
Journal:  Clin Med (Lond)       Date:  2018-10       Impact factor: 2.659

7.  Valproic acid-induced abnormal behavior.

Authors:  Nanjangud Chandrashekar Nagalakshmi; Madhan Ramesh; Gurumurthy Parthasarathi; Anand Harugeri; Mary Sam Christy; Belur Seshachala Keshava
Journal:  Indian J Psychiatry       Date:  2010-01       Impact factor: 1.759

8.  Reversible weakness and encephalopathy while on long-term valproate treatment due to carnitine deficiency.

Authors:  Ahmed Al-sharefi; Rudy Bilous
Journal:  BMJ Case Rep       Date:  2015-09-02

Review 9.  Delirium: sifting through the confusion.

Authors:  Raheel A Khan; Debra Kahn; James A Bourgeois
Journal:  Curr Psychiatry Rep       Date:  2009-06       Impact factor: 5.285

10.  Valproate Induced Hyperammonemic Delirium.

Authors:  Anupama Muraleedharan; Dhanya Sasidharan Palappallil; Reneega Gangadhar; Soumitra Das
Journal:  J Clin Diagn Res       Date:  2015-12-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.